Probenecid

In the US, Probenecid (probenecid systemic) is a member of the drug class antigout agents and is used to treat Adjunct to Antibiotic Therapy and Gout.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

M04AB01

CAS registry number (Chemical Abstracts Service)

0000057-66-9

Chemical Formula

C13-H19-N-O4-S

Molecular Weight

285

Therapeutic Category

Uricosuric agent

Chemical Name

Benzoic acid, 4-[(dipropylamino)sulfonyl]-

Foreign Names

  • Probenecidum (Latin)
  • Probenecid (German)
  • Probénécide (French)
  • Probenecida (Spanish)

Generic Names

  • Probenecid (OS: DCIT, JAN, BAN)
  • Probénécide (OS: DCF)
  • Probenecid (PH: BP 2011, JP XV, Ph. Eur. 7, Ph. Int. 4, USP 34)
  • Probénécide (PH: Ph. Eur. 7)
  • Probenecidum (PH: Ph. Eur. 7, Ph. Int. 4)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web5)